Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...

Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers ...

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy offers low-dose naltrexone, ketamine, and other alternative treatment options for the growing mental health crisis in the United States.

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy, having recently renovated and expanded its lab and office space to support growing customer demand, announces it is ready to take on ...

Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's ...

CurifyLabs today announced the rollout of its latest innovation in compounding pharmacy technology, the CurifyLabs PharmaPrinter Aurum. The newest evolution of the CurifyLabs Compounding System ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging ...